{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T21:49:17Z","timestamp":1793137757202,"version":"4.5.0"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82002574"],"award-info":[{"award-number":["82002574"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.lfs.2021.119399","type":"journal-article","created":{"date-parts":[[2021,3,27]],"date-time":"2021-03-27T03:37:57Z","timestamp":1616816277000},"page":"119399","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":242,"special_numbering":"C","title":["Exosomal miR-4443 promotes cisplatin resistance in non-small cell lung carcinoma by regulating FSP1 m6A modification-mediated ferroptosis"],"prefix":"10.1016","volume":"276","author":[{"given":"Zhiyu","family":"Song","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peizhi","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shundong","family":"Cang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7689","key":"10.1016\/j.lfs.2021.119399_bb0005","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/nature25183","article-title":"The biology and management of non-small cell lung cancer","volume":"553","author":"Herbst","year":"2018","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.lfs.2021.119399_bb0010","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/nrc3775","article-title":"Non-small-cell lung cancers: a heterogeneous set of diseases","volume":"14","author":"Chen","year":"2014","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.lfs.2021.119399_bb0015","doi-asserted-by":"crossref","unstructured":"Gridelli C, Morabito A, Cavanna L, Luciani A, Maione P, Bonanno L, Filipazzi V, Leo S, Cinieri S, Ciardiello F et al: Cisplatin-based first-line treatment of elderly patients with advanced non-small-cell lung cancer: joint analysis of MILES-3 and MILES-4 phase III trials. J. Clin. Oncol. 2018, 36(25):2585\u20132592.","DOI":"10.1200\/JCO.2017.76.8390"},{"issue":"2","key":"10.1016\/j.lfs.2021.119399_bb0020","doi-asserted-by":"crossref","DOI":"10.4143\/crt.2016.572","article-title":"Ferroptosis: a novel anti-tumor action for cisplatin","volume":"50","author":"Guo","year":"2017","journal-title":"Cancer Research & Treatment Official Journal of Korean Cancer Association"},{"key":"10.1016\/j.lfs.2021.119399_bb0025","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.lungcan.2019.07.010","article-title":"Efficacy and safety of first-line carboplatin-versus cisplatin-based chemotherapy for non-small cell lung cancer: a meta-analysis","volume":"135","author":"Griesinger","year":"2019","journal-title":"Lung Cancer"},{"issue":"3","key":"10.1016\/j.lfs.2021.119399_bb0030","doi-asserted-by":"crossref","first-page":"288","DOI":"10.21037\/tlcr.2016.06.07","article-title":"Non-small cell lung cancer: current treatment and future advances","volume":"5","author":"Zappa","year":"2016","journal-title":"Transl Lung Cancer Res"},{"key":"10.1016\/j.lfs.2021.119399_bb0035","doi-asserted-by":"crossref","unstructured":"MacDonagh L, Gray SG, Breen E, Cuffe S, Finn SP, O'Byrne KJ, Barr MP: BBI608 inhibits cancer stemness and reverses cisplatin resistance in NSCLC. Cancer Lett. 2018, 428:117\u2013126.","DOI":"10.1016\/j.canlet.2018.04.008"},{"issue":"1","key":"10.1016\/j.lfs.2021.119399_bb0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7150\/ijbs.27796","article-title":"Current progresses of exosomes as cancer diagnostic and prognostic biomarkers","volume":"15","author":"Huang","year":"2019","journal-title":"Int. J. Biol. Sci."},{"issue":"2","key":"10.1016\/j.lfs.2021.119399_bb0045","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.cell.2019.02.029","article-title":"Reassessment of exosome composition","volume":"177","author":"Jeppesen","year":"2019","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.lfs.2021.119399_bb0050","doi-asserted-by":"crossref","DOI":"10.1186\/s13046-017-0528-y","article-title":"Exosomal transfer of tumor-associated macrophage-derived miR-21 confers cisplatin resistance in gastric cancer cells","volume":"36","author":"Zheng","year":"2017","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"7","key":"10.1016\/j.lfs.2021.119399_bb0055","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djv135","article-title":"Exosome-mediated transfer of microRNAs within the tumor microenvironment and neuroblastoma resistance to chemotherapy","volume":"107","author":"Challagundla","year":"2015","journal-title":"J. Natl. Cancer Inst."},{"issue":"1","key":"10.1016\/j.lfs.2021.119399_bb0060","doi-asserted-by":"crossref","DOI":"10.1186\/s13046-018-0901-5","article-title":"The roles of tumor-derived exosomes in non-small cell lung cancer and their clinical implications","volume":"37","author":"Zheng","year":"2018","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.lfs.2021.119399_bb0065","doi-asserted-by":"crossref","unstructured":"Wei F, Ma C, Zhou T, Dong X, Luo Q, Geng L, Ding L, Zhang Y, Zhang L, Li N et al: Exosomes derived from gemcitabine-resistant cells transfer malignant phenotypic traits via delivery of miRNA-222-3p. Mol. Cancer 2017, 16(1):132.","DOI":"10.1186\/s12943-017-0694-8"},{"key":"10.1016\/j.lfs.2021.119399_bb0070","doi-asserted-by":"crossref","unstructured":"Ma Y, Yuwen D, Chen J, Zheng B, Gao J, Fan M, Xue W, Wang Y, Li W, Shu Y et al: Exosomal transfer of cisplatin-induced miR-425-3p confers cisplatin resistance in NSCLC through activating autophagy. Int. J. Nanomedicine 2019, 14:8121\u20138132.","DOI":"10.2147\/IJN.S221383"},{"issue":"5","key":"10.1016\/j.lfs.2021.119399_bb0075","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1007\/s00404-019-05107-x","article-title":"Downregulation of miR-4443 and miR-5195-3p in ovarian cancer tissue contributes to metastasis and tumorigenesis","volume":"299","author":"Ebrahimi","year":"2019","journal-title":"Arch. Gynecol. Obstet."},{"issue":"1","key":"10.1016\/j.lfs.2021.119399_bb0080","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-016-2938-1","article-title":"Leptin and insulin up-regulate miR-4443 to suppress NCOA1 and TRAF4, and decrease the invasiveness of human colon cancer cells","volume":"16","author":"Meerson","year":"2016","journal-title":"BMC Cancer"},{"key":"10.1016\/j.lfs.2021.119399_bb0085","doi-asserted-by":"crossref","DOI":"10.1177\/0963689720927405","article-title":"Long noncoding RNA LINC00460 promotes cell progression by sponging miR-4443 in head and neck squamous cell carcinoma","volume":"29","author":"Li","year":"2020","journal-title":"Cell Transplant."},{"issue":"3","key":"10.1016\/j.lfs.2021.119399_bb0090","doi-asserted-by":"crossref","first-page":"341","DOI":"10.3727\/096504018X15228909735079","article-title":"lncRNA MNX1-AS1 promotes glioblastoma progression through inhibition of miR-4443","volume":"27","author":"Gao","year":"2019","journal-title":"Oncol. Res."},{"key":"10.1016\/j.lfs.2021.119399_bb0095","unstructured":"Zhang W, Qiao B, Fan J: Overexpression of miR-4443 promotes the resistance of non-small cell lung cancer cells to epirubicin by targeting INPP4A and regulating the activation of JAK2\/STAT3 pathway. Pharmazie 2018, 73(7):386\u2013392."},{"issue":"26","key":"10.1016\/j.lfs.2021.119399_bb0100","doi-asserted-by":"crossref","first-page":"42125","DOI":"10.18632\/oncotarget.15009","article-title":"Comparative analysis of microRNA expression profiles between A549, A549\/DDP and their respective exosomes","volume":"8","author":"Qin","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.lfs.2021.119399_bb0105","doi-asserted-by":"crossref","unstructured":"Vella LJ, Scicluna BJ, Cheng L, Bawden EG, Masters CL, Ang CS, Willamson N, McLean C, Barnham KJ, Hill AF: A rigorous method to enrich for exosomes from brain tissue. J Extracell Vesicles 2017, 6(1):1348885.","DOI":"10.1080\/20013078.2017.1348885"},{"key":"10.1016\/j.lfs.2021.119399_bb0110","doi-asserted-by":"crossref","unstructured":"Rikkert LG, Nieuwland R, Terstappen L, Coumans FAW: Quality of extracellular vesicle images by transmission electron microscopy is operator and protocol dependent. J Extracell Vesicles 2019, 8(1):1555419.","DOI":"10.1080\/20013078.2018.1555419"},{"issue":"14","key":"10.1016\/j.lfs.2021.119399_bb0115","doi-asserted-by":"crossref","first-page":"E2047","DOI":"10.1073\/pnas.1602883113","article-title":"Hypoxia induces the breast cancer stem cell phenotype by HIF-dependent and ALKBH5-mediated m(6)A-demethylation of NANOG mRNA","volume":"113","author":"Zhang","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"12","key":"10.1016\/j.lfs.2021.119399_bb0120","doi-asserted-by":"crossref","first-page":"6130","DOI":"10.1093\/nar\/gkz312","article-title":"Zfp217 mediates m6A mRNA methylation to orchestrate transcriptional and post-transcriptional regulation to promote adipogenic differentiation","volume":"47","author":"Song","year":"2019","journal-title":"Nucleic Acids Res."},{"issue":"3\u20134","key":"10.1016\/j.lfs.2021.119399_bb0125","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1007\/s10495-019-01515-1","article-title":"Chemotherapeutic paclitaxel and cisplatin differentially induce pyroptosis in A549 lung cancer cells via caspase-3\/GSDME activation","volume":"24","author":"Zhang","year":"2019","journal-title":"Apoptosis"},{"issue":"7","key":"10.1016\/j.lfs.2021.119399_bb0130","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1007\/s10529-017-2325-2","article-title":"MiR-9 enhances the sensitivity of A549 cells to cisplatin by inhibiting autophagy","volume":"39","author":"Zhang","year":"2017","journal-title":"Biotechnol. Lett."},{"issue":"5","key":"10.1016\/j.lfs.2021.119399_bb0135","doi-asserted-by":"crossref","first-page":"e2803","DOI":"10.1038\/cddis.2017.210","article-title":"Cytoplasmic RAP1 mediates cisplatin resistance of non-small cell lung cancer","volume":"8","author":"Xiao","year":"2017","journal-title":"Cell Death Dis."},{"issue":"4","key":"10.1016\/j.lfs.2021.119399_bb0140","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.bbrc.2016.11.077","article-title":"MiR-33a suppresses proliferation of NSCLC cells via targeting METTL3 mRNA","volume":"482","author":"Du","year":"2016","journal-title":"Biochemical & Biophysical Research Communications"},{"issue":"1","key":"10.1016\/j.lfs.2021.119399_bb0145","doi-asserted-by":"crossref","DOI":"10.1186\/s12943-018-0847-4","article-title":"Novel insights on m6A RNA methylation in tumorigenesis: a double-edged sword","volume":"17","author":"Wang","year":"2018","journal-title":"Mol. Cancer"},{"issue":"7784","key":"10.1016\/j.lfs.2021.119399_bb0150","doi-asserted-by":"crossref","DOI":"10.1038\/s41586-019-1707-0","article-title":"FSP1 is a glutathione-independent ferroptosis suppressor","volume":"575","author":"Doll","year":"2019","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.lfs.2021.119399_bb0155","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","article-title":"Ferroptosis: an iron-dependent form of nonapoptotic cell death","volume":"149","author":"Dixon","year":"2012","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.lfs.2021.119399_bb0160","doi-asserted-by":"crossref","first-page":"445","DOI":"10.4143\/crt.2016.572","article-title":"Ferroptosis: a novel anti-tumor action for cisplatin","volume":"50","author":"Guo","year":"2018","journal-title":"Cancer Res. Treat."},{"issue":"7","key":"10.1016\/j.lfs.2021.119399_bb0165","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.4161\/auto.20123","article-title":"Suppression of basal autophagy reduces lung cancer cell proliferation and enhances caspase-dependent and -independent apoptosis by stimulating ROS formation","volume":"8","author":"Kaminskyy","year":"2012","journal-title":"Autophagy"},{"issue":"11","key":"10.1016\/j.lfs.2021.119399_bb0170","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1002\/cbin.11121","article-title":"The induction of ferroptosis by impairing STAT3\/Nrf2\/GPx4 signaling enhances the sensitivity of osteosarcoma cells to cisplatin","volume":"43","author":"Liu","year":"2019","journal-title":"Cell Biol. Int."},{"key":"10.1016\/j.lfs.2021.119399_bb0175","doi-asserted-by":"crossref","unstructured":"Li Y, Yan H, Xu X, Liu H, Wu C, Zhao L: Erastin\/sorafenib induces cisplatin-resistant non-small cell lung cancer cell ferroptosis through inhibition of the Nrf2\/xCT pathway. Oncol. Lett. 2020, 19(1):323\u2013333.","DOI":"10.3892\/ol.2019.11066"},{"issue":"7784","key":"10.1016\/j.lfs.2021.119399_bb0180","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/s41586-019-1707-0","article-title":"FSP1 is a glutathione-independent ferroptosis suppressor","volume":"575","author":"Doll","year":"2019","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.lfs.2021.119399_bb0185","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.bbrc.2016.11.077","article-title":"MiR-33a suppresses proliferation of NSCLC cells via targeting METTL3 mRNA","volume":"482","author":"Du","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.lfs.2021.119399_bb0190","doi-asserted-by":"crossref","unstructured":"Wei W, Huo B, Shi X: miR-600 inhibits lung cancer via downregulating the expression of METTL3. Cancer Manag. Res. 2019, 11:1177\u20131187.","DOI":"10.2147\/CMAR.S181058"},{"issue":"2","key":"10.1016\/j.lfs.2021.119399_bb0195","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-017-0129-x","article-title":"N6-methyladenosine links RNA metabolism to cancer progression","volume":"9","author":"Dai","year":"2018","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.lfs.2021.119399_bb0200","doi-asserted-by":"crossref","unstructured":"Liu Y, You Y, Lu Z, Yang J, Li P, Liu L, Xu H, Niu Y, Cao X: N (6)-methyladenosine RNA modification-mediated cellular metabolism rewiring inhibits viral replication. Science 2019, 365(6458):1171\u20131176.","DOI":"10.1126\/science.aax4468"},{"issue":"7683","key":"10.1016\/j.lfs.2021.119399_bb0205","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1038\/nature24678","article-title":"Promoter-bound METTL3 maintains myeloid leukaemia by m(6)A-dependent translation control","volume":"552","author":"Barbieri","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.lfs.2021.119399_bb0210","doi-asserted-by":"crossref","unstructured":"Zheng W, Dong X, Zhao Y, Wang S, Jiang H, Zhang M, Zheng X, Gu M: Multiple functions and mechanisms underlying the role of METTL3 in human cancers. Front. Oncol. 2019, 9:1403.","DOI":"10.3389\/fonc.2019.01403"},{"issue":"2","key":"10.1016\/j.lfs.2021.119399_bb0215","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/s41397-019-0110-4","article-title":"Dissecting the m(6)A methylation affection on afatinib resistance in non-small cell lung cancer","volume":"20","author":"Meng","year":"2020","journal-title":"Pharmacogenomics J"},{"issue":"11","key":"10.1016\/j.lfs.2021.119399_bb0220","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1038\/s41422-018-0097-4","article-title":"A dynamic N(6)-methyladenosine methylome regulates intrinsic and acquired resistance to tyrosine kinase inhibitors","volume":"28","author":"Yan","year":"2018","journal-title":"Cell Res."},{"issue":"3\u20134","key":"10.1016\/j.lfs.2021.119399_bb0225","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s10495-020-01591-8","article-title":"DDX3 modulates cisplatin resistance in OSCC through ALKBH5-mediated m(6)A-demethylation of FOXM1 and NANOG","volume":"25","author":"Shriwas","year":"2020","journal-title":"Apoptosis"},{"issue":"9","key":"10.1016\/j.lfs.2021.119399_bb0230","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1158\/1541-7786.MCR-10-0052","article-title":"Loss of miR-200c expression induces an aggressive, invasive, and chemoresistant phenotype in non-small cell lung cancer","volume":"8","author":"Ceppi","year":"2010","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.lfs.2021.119399_bb0235","unstructured":"Yuwen DL, Sheng BB, Liu J, Wenyu W, Shu YQ: MiR-146a-5p level in serum exosomes predicts therapeutic effect of cisplatin in non-small cell lung cancer. European Review for Medical & Pharmacological Sciences 2017."},{"issue":"17","key":"10.1016\/j.lfs.2021.119399_bb0240","doi-asserted-by":"crossref","first-page":"3513","DOI":"10.1038\/emboj.2012.183","article-title":"Tumour-secreted miR-9 promotes endothelial cell migration and angiogenesis by activating the JAK-STAT pathway","volume":"31","author":"Zhuang","year":"2012","journal-title":"EMBO J."},{"key":"10.1016\/j.lfs.2021.119399_bb0245","doi-asserted-by":"crossref","unstructured":"Florczuk M, Szpechcinski A, Chorostowska-Wynimko J: miRNAs as biomarkers and therapeutic targets in non-small cell lung cancer: current perspectives. Target. Oncol. 2017, 12(2):1\u201322.","DOI":"10.1007\/s11523-017-0478-5"}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320521003842?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320521003842?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T18:31:24Z","timestamp":1719858684000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320521003842"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":49,"alternative-id":["S0024320521003842"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2021.119399","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exosomal miR-4443 promotes cisplatin resistance in non-small cell lung carcinoma by regulating FSP1 m6A modification-mediated ferroptosis","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2021.119399","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"119399"}}